IAM
CMD

Integre Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Integre Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$207K Buy
2,918
+225
+8% +$16.3K 0.12% 112
2019
Q3 		$201K Buy
+2,693
New +$228K 0.12% 107

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Integre Asset Management's CMD Position: Q4 2019 in Review

Integre Asset Management increased its Cantel Medical Corporation (CMD) stake by 8.4% in Q4 2019, buying an estimated $16.3K and bringing the position to 2,918 shares worth $207K. The position accounts for 0.12% of the portfolio, ranked #112.

Integre Asset Management first reported a position in CMD in Q3 2019 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold CMD as of Q4 2019.

  • Integre Asset Management held 2,918 shares of Cantel Medical Corporation worth $207K as of Q4 2019.
  • Integre Asset Management bought 225 Cantel Medical Corporation shares in Q4 2019, an estimated $16.3K.
  • Cantel Medical Corporation made up 0.12% of Integre Asset Management's portfolio in Q4 2019, its #112 holding.
  • Integre Asset Management first reported a position in Cantel Medical Corporation in Q3 2019 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2019.

Based on Integre Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.